Blood Plasma: Market Shares, Strategies, and Forecasts, Worldwide, 2018 to 2024

$4300 - Single Copy or $8600 - Web Posting | Report # SH28074732 | 338 Pages | 148 Tables and Figures | 2018


Qty
Authorize.net
  • Key Topics
  • Blood
  • Plasma proteins
  • Immunoglobulins
  • Albumin
  • Hemophilia factor proteins
  • Fractionation
  • Serum
  • Blood Plasma
  • Proteins Components of Blood
  • Liver Disease
  • Viral Hepatitis (Predominantly Hepatitis B
  • Mandatory HCV Screening
  • Blood Transfusion
  • High Mortality From Liver Diseases
  • Serum Albumin, A Substance Found In Human Blood Plasma
  • Blood Acquired HIV from Unsanitary Needles

YOU MUST HAVE THIS STUDY


LEXINGTON, Massachusetts (October 30, 2018) – WinterGreen Research announces that it has published a new study Blood Plasma: Market Shares, Strategy, and Forecasts, Worldwide, 2018 to 2024.  The 2018 study has 338 pages, 148 tables and figures.  Worldwide markets are poised to achieve continuing growth as animal and human blood is further fractionated to address more disease treatments and becomes more effective in the research and development aspects of medical care delivery.

Blood is for most species the essence of life.  Blood plasma provides significant health benefits.  The varieties of proteins and other components of blood are in demand worldwide.  Blood proves its value by managing a variety of ways to treat disease.  

The plasma proteins or derivatives in blood are extracted via the fractionation process. A range of valuable products are manufactured from blood plasma through fractionation.  Fractionation occurs in tanks at near freezing temperatures.  Fractionation is used to maintain the integrity of the proteins in plasma.  This process includes a phase of introducing various viral inactivation procedures.  

Blood plasma offers high value for its volume and weight.  One refrigerated container might be worth more than an entire shipload of grain.  Blood provides significant health benefits to people.  Blood exports boost U.S. exports with minimal carbon emissions.

Liver disease is a major cause of illness and death worldwide. In China, 400 million people have liver diseases, primarily viral hepatitis (predominantly hepatitis B virus [HBV]).  Nonalcoholic fatty liver disease and alcoholic liver diseases are also prevalent diagnoses.

The blood plasma market is driven in part by China, and by demand from China for high quality blood from the US.  Chinese patients consumed 400 metric tons of serum albumin in 2017, half of the global total of that blood protein.  The necessary supply could be provided by the Chinese population, but, many of them are afraid to donate blood.  

The reason is a well-remembered 1990s health scare in which tens of thousands of farmers who had been paid to donate blood acquired HIV from unsanitary needles. The ensuing scandal was covered up by the government.

As a result, China has to import about 60% of its serum albumin—and the ever-rising demand has driven up prices.  American companies have an edge in the Chinese markets because of the quality of the blood collected.  The edge is apparent in the fact that three foreign companies account for 88% of China’s serum albumin imports.

The billion-dollar market for blood worldwide has a variety of participants.  Thermo Fsher Scientific has the largest market participation.   Sales of blood therapeutics were $30.9 billion in 2017.  By 2024, these products reach $57.5 billion, reflecting a five-year CAGR of 8.2%.

WinterGreen Research is an independent research organization funded by the sale of market research studies all over the world and by the implementation of ROI models that are used to calculate the total cost of ownership of equipment, services, and software.  The company has 35 distributors worldwide, including Global Information Info Shop, Market Research.com, Research and Markets, electronics.ca, Bloomberg, and Thompson Financial.  

WinterGreen Research is positioned to help customers facing challenges that define the modern enterprises. The increasingly global nature of science, technology and engineering is a reflection of the implementation of the globally integrated enterprise.  Customers trust wintergreen research to work alongside them to ensure the success of the participation in a particular market segment.

WinterGreen Research supports various market segment programs; provides trusted technical services to the marketing departments.  It carries out accurate market share and forecast analysis services for a range of commercial and government customers globally.  These are all vital market research support solutions requiring trust and integrity.

Companies Profiled
Market Leaders
  • Thermo Fisher Scientific
  • Takeda / Shire / Baxalta
  • Grifols S.A
  • Avantor / VWR
  • Corning
  • GE Healthcare
  • Octapharma
  • China Biologic Products Holdings
  • ANZCO Foods / Bovogen Biologicals
  • Biotest
  • Global Cord Blood
  • Rocky Mountain Biologicals 

Report Methodology

This is the 807th report in a series of market research reports that provide forecasts in communications, telecommunications, the internet, computer, software, and telephone equipment. The project leaders take direct responsibility for writing and preparing each report. They have significant experience preparing industry studies. Forecasts are based on primary research and proprietary databases. Forecasts reflect analysis of the market trends in the segment and related segments. Unit and dollar shipments are analyzed through consideration of dollar volume of each market participation in the segment. Market share analysis includes conversations with key customers of products, industry segment leaders, marketing directors, distributors, leading market participants, and companies seeking to develop measurable market share. Over 200 in-depth interviews are conducted for each report with a broad range of key participants and opinion leaders in the market segment.

About the Company

WinterGreen Research, founded in 1985, provides strategic market assessments in telecommunications, communications equipment, health care, and advanced computer technology. Industry reports focus on opportunities that will expand existing markets or develop major new markets. The reports assess new product and service positioning strategies, new and evolving technologies, and technological impact on products, services, and markets. Market shares are provided. Leading market participants are profiled, and their marketing strategies, acquisitions, and strategic alliances are discussed. The principals of WinterGreen Research have been involved in analysis and forecasting of international business opportunities in telecommunications and advanced computer technology markets for over 30 years.

About the Principal Authors

Ellen T. Curtiss, Technical Director, co-founder of WinterGreen Research, conducts strategic and market assessments in technology-based industries. Previously she was a member of the staff of Arthur D. Little, Inc., for 23 years, most recently as Vice President of Arthur D. Little Decision Resources, specializing in strategic planning and market development services. She is a graduate of Boston University and the Program for Management Development at Harvard Graduate School of Business Administration. She is the author of recent studies on worldwide telecommunications markets and the Top Ten Telecommunications market analysis and forecasts.

Susan Eustis, President, co-founder of WinterGreen Research, has done research in communications and computer markets and applications. She holds several patents in microcomputing and parallel processing. She is the author of recent studies of the Service Oriented Architecture (SOA) marketing strategies, Internet software, a study of Push to Talk Equipment, Worldwide Telecommunications Equipment, Top Ten Telecommunications, Digital Loop Carrier, Web Hosting, Business Process Management, Servers, Blades, the Mainframe as a Green Machine, and Application Server markets. Ms. Eustis is a graduate of Barnard College.

$4300 - Single Copy or $8600 - Web Posting | Report # SH28074732 | 338 Pages | 148 Tables and Figures | 2018


Qty
Authorize.net